In brief
The novel synthetic tranquiliser ‘tranq’ is reshaping America’s drug crisis, but churches in Ohio have responded by opening doors as safe‑havens for those battling addiction. Pastor Daniel Reyes of First Baptist in Columbus says faith communities are stepping out of the pulpit to provide counselling, drug‑testing kiosks and peer‑support groups. Public‑health experts warn that even with these community‑based approaches, tighter controls on the supply chain are still needed. The BBC’s on‑site coverage documents how these initiatives are part of a broader, multi‑pronged strategy to curb the spread of potent street‑laced drugs.
The Church as a shield, the community as a response unit: In Ohio, faith leaders are confronting the surge of a potent synthetic tranquiliser dubbed “tranq”.
The war on drugs has long been characterised by law‑enforcement raids and policy debates, but the new players—cartels distributing the animal musk tranquiliser, mislabeled or mixed with other opioids—have forced the U.S. to look elsewhere for help. Congregations have answered that call, offering outreach, counselling and safe‑spaces for those caught in the drug's deadly grip.
“We feel it’s our moral duty to step into the streets and offer a word of hope,” says Pastor Daniel Reyes of First Baptist in Columbus. “People who feel alienated by the health system often turn to our doors.”
Sights outside the church counters a fresh influx of synthetic sedatives: street‑labeled “tranq” can be up to 40‑times stronger than prescription Valium, and its unregulated manufacture leads to unpredictable potencies.
Recovery workers point out the trend: “Overdose deaths linked to fentanyl have dropped, yet the arrival of tranq is shifting the curve,” notes Dr. Maya Patel, a public‑health researcher at Ohio State. “The community must pivot to reduce demand and provide tailored support.”
During a recent trip to Columbus, BBC International correspondent Quentin Sommerville and camera journalist Darren Conway witnessed the church‑led harm‑reduction programmes in action—including safe‑drop sites, peer‑support groups and drug‑testing kiosks outside the church compound.
These initiatives, coupled with state‑backed prescription monitoring, are part of a broader multi‑pronged strategy to curb the spread of these synthetic compounds. Yet some experts warn that without tighter regulatory controls on the supply chain, faith‑based programs alone may struggle to stem the tide.
For more details on how the U.S. is addressing the wave of homemade, synthetic drugs, read our full coverage.
